Data / Form D filings / FST Life Sciences, Inc.
FST Life Sciences, Inc.: Form D filings
FST Life Sciences, Inc., a pharmaceuticals company in Ann Arbor, MI, filed 2 Form D notices with the SEC in 2010. The latest, on September 14, 2010, reports $1.1 million sold of a $1.3 million offering to 9 investors.
Find out what FST Life Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 S. MAIN STREET, SUITE 900, Ann Arbor, MI, 48104
- Phone
- (216) 702-0094
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2006
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1400452
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2010 | Amendment | $1,341,632 | $1,082,192 | $259,440 | 9 | Jun 3, 2010 | sec.gov |
| Jun 17, 2010 | New notice | $1,091,632 | $707,192 | $384,440 | 7 | Jun 3, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew McColm | Director | |
| Michael Bunker | Director | |
| Thomas Holleran | Executive Officer, Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Sep 13, 2010 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what FST Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.